BACKGROUND: Scoliosis is a feature of several genetic disorders that are also associated with aortic aneurysm, including Marfan syndrome, Loeys-Dietz syndrome, and type-IV Ehlers-Danlos syndrome. Life-threatening complications of aortic aneurysm can be decreased through early diagnosis. Genetic screening for mutations in populations at risk, such as patients with adolescent idiopathic scoliosis, may improve recognition of these disorders. METHODS: The coding regions of five clinically actionable genes associated with scoliosis (COL3A1, FBN1, TGFBR1, TGFBR2, and SMAD3) and aortic aneurysm were sequenced in 343 adolescent idiopathic scoliosis cases. Gene variants that had minor allele frequencies of <0.0001 or were present in human disease mutation databases were identified. Variants were classified as pathogenic, likely pathogenic, or variants of unknown significance. RESULTS: Pathogenic or likely pathogenic mutations were identified in 0.9% (three) of 343 adolescent idiopathic scoliosis cases. Two patients had pathogenic SMAD3 nonsense mutations consistent with type-III Loeys-Dietz syndrome and one patient had a pathogenic FBN1 mutation with subsequent confirmation of Marfan syndrome. Variants of unknown significance in COL3A1 and FBN1 were identified in 5.0% (seventeen) of 343 adolescent idiopathic scoliosis cases. Six FBN1 variants were previously reported in patients with Marfan syndrome, yet were considered variants of unknown significance based on the level of evidence. Variants of unknown significance occurred most frequently in FBN1 and were associated with greater curve severity, systemic features of Marfan syndrome, and joint hypermobility. CONCLUSIONS: Clinically actionable pathogenic mutations in genes associated with adolescent idiopathic scoliosis and aortic aneurysm are rare in patients with adolescent idiopathic scoliosis who are not suspected of having these disorders, although variants of unknown significance are relatively common. CLINICAL RELEVANCE: Routine genetic screening of all patients with adolescent idiopathic scoliosis for mutations in clinically actionable aortic aneurysm disease genes is not recommended on the basis of the high frequency of variants of unknown significance. Clinical evaluation and family history should heighten indications for genetic referral and testing.
BACKGROUND:Scoliosis is a feature of several genetic disorders that are also associated with aortic aneurysm, including Marfan syndrome, Loeys-Dietz syndrome, and type-IV Ehlers-Danlos syndrome. Life-threatening complications of aortic aneurysm can be decreased through early diagnosis. Genetic screening for mutations in populations at risk, such as patients with adolescent idiopathic scoliosis, may improve recognition of these disorders. METHODS: The coding regions of five clinically actionable genes associated with scoliosis (COL3A1, FBN1, TGFBR1, TGFBR2, and SMAD3) and aortic aneurysm were sequenced in 343 adolescent idiopathic scoliosis cases. Gene variants that had minor allele frequencies of <0.0001 or were present in human disease mutation databases were identified. Variants were classified as pathogenic, likely pathogenic, or variants of unknown significance. RESULTS: Pathogenic or likely pathogenic mutations were identified in 0.9% (three) of 343 adolescent idiopathic scoliosis cases. Two patients had pathogenic SMAD3 nonsense mutations consistent with type-III Loeys-Dietz syndrome and one patient had a pathogenic FBN1 mutation with subsequent confirmation of Marfan syndrome. Variants of unknown significance in COL3A1 and FBN1 were identified in 5.0% (seventeen) of 343 adolescent idiopathic scoliosis cases. Six FBN1 variants were previously reported in patients with Marfan syndrome, yet were considered variants of unknown significance based on the level of evidence. Variants of unknown significance occurred most frequently in FBN1 and were associated with greater curve severity, systemic features of Marfan syndrome, and joint hypermobility. CONCLUSIONS: Clinically actionable pathogenic mutations in genes associated with adolescent idiopathic scoliosis and aortic aneurysm are rare in patients with adolescent idiopathic scoliosis who are not suspected of having these disorders, although variants of unknown significance are relatively common. CLINICAL RELEVANCE: Routine genetic screening of all patients with adolescent idiopathic scoliosis for mutations in clinically actionable aortic aneurysm disease genes is not recommended on the basis of the high frequency of variants of unknown significance. Clinical evaluation and family history should heighten indications for genetic referral and testing.
Authors: Ingrid M B H van de Laar; Denise van der Linde; Edwin H G Oei; Pieter K Bos; Johannes H Bessems; Sita M Bierma-Zeinstra; Belle L van Meer; Gerard Pals; Rogier A Oldenburg; Jos A Bekkers; Adriaan Moelker; Bianca M de Graaf; Gabor Matyas; Ingrid M E Frohn-Mulder; Janneke Timmermans; Yvonne Hilhorst-Hofstee; Jan M Cobben; Hennie T Bruggenwirth; Lut van Laer; Bart Loeys; Julie De Backer; Paul J Coucke; Harry C Dietz; Patrick J Willems; Ben A Oostra; Anne De Paepe; Jolien W Roos-Hesselink; Aida M Bertoli-Avella; Marja W Wessels Journal: J Med Genet Date: 2012-01 Impact factor: 6.318
Authors: Gurkan Erkula; Paul D Sponseller; Laura C Paulsen; Gretchen L Oswald; Bart L Loeys; Harry C Dietz Journal: J Bone Joint Surg Am Date: 2010-08-04 Impact factor: 5.284
Authors: Paul D Sponseller; Gurkan Erkula; Richard L Skolasky; Kristen D Venuti; Harry C Dietz Journal: J Bone Joint Surg Am Date: 2010-08-04 Impact factor: 5.284
Authors: Mohammad Diab; Zachary Landman; John Lubicky; John Dormans; Mark Erickson; B Stephens Richards Journal: Spine (Phila Pa 1976) Date: 2011-04-15 Impact factor: 3.468
Authors: Ingrid M B H van de Laar; Rogier A Oldenburg; Gerard Pals; Jolien W Roos-Hesselink; Bianca M de Graaf; Judith M A Verhagen; Yvonne M Hoedemaekers; Rob Willemsen; Lies-Anne Severijnen; Hanka Venselaar; Gert Vriend; Peter M Pattynama; Margriet Collée; Danielle Majoor-Krakauer; Don Poldermans; Ingrid M E Frohn-Mulder; Dimitra Micha; Janneke Timmermans; Yvonne Hilhorst-Hofstee; Sita M Bierma-Zeinstra; Patrick J Willems; Johan M Kros; Edwin H G Oei; Ben A Oostra; Marja W Wessels; Aida M Bertoli-Avella Journal: Nat Genet Date: 2011-01-09 Impact factor: 38.330
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Gabe Haller; Hannah Zabriskie; Shelby Spehar; Timothy Kuensting; Xavier Bledsoe; Ali Syed; Christina A Gurnett; Matthew B Dobbs Journal: J Pediatr Orthop B Date: 2018-03 Impact factor: 1.041
Authors: Brooke Sadler; Gabe Haller; Lilian Antunes; Xavier Bledsoe; Jose Morcuende; Philip Giampietro; Cathleen Raggio; Nancy Miller; Yared Kidane; Carol A Wise; Ina Amarillo; Nephi Walton; Mark Seeley; Darren Johnson; Conner Jenkins; Troy Jenkins; Matthew Oetjens; R Spencer Tong; Todd E Druley; Matthew B Dobbs; Christina A Gurnett Journal: J Med Genet Date: 2019-02-25 Impact factor: 6.318